key: cord-0732844-11givtxz
authors: Haro, García; Bischofberger Valdés, Cornelia; Vicente-Guijarro, Jorge; Díaz-Agero Pérez, Cristina; Fabregate-Fuente, Martín; Moreno-Nunez, Paloma; Aranaz Andrés, Jesús María
title: Filtering facepiece respirators decontamination using a low-temperature-steam-2% formaldehyde sterilisation process during a pandemic: a safe alternative for reuse
date: 2020-11-04
journal: J Hosp Infect
DOI: 10.1016/j.jhin.2020.10.024
sha: 565a0796610e7249358a7b28fa0bba1d158ef46d
doc_id: 732844
cord_uid: 11givtxz

Background: the COVID-19 pandemic has caused problems with respirator supplies. Reuse may minimise the impact of the shortage but requires the availability of an efficient and safe decontamination method. AIM: our objective is to determine whether the low-temperature-steam-2%-formaldehyde (LTSF) sterilisation process is effective, preserves the properties of filtering facepiece (FFP) respirators and allows safe reuse. METHODS: 14 unused FFP2, FFP3 and N95 respirator models were subjected to two decontamination cycles. After the second cycle, each model was visually inspected and accumulated residual formaldehyde levels were analysed according to the EN 14180. After one and two cycles, Fit factor (FF) was tested on all models and penetration tests with sodium chloride (NaCl) aerosols were additionally performed on five models. FINDINGS: decontamination physically altered three of the 14 models. All the residual formaldehyde values were below the permissible threshold. Irregular FF decreases and increases were observed after each cycle. In the sodium chloride (NaCl) aerosol penetration test, three devices obtained equivalent or superior results to those of the FFP classification with which they were marketed, both at the baseline level and after one and two decontamination cycles. Two other devices reduced their filtering capacity. CONCLUSION: One and two sterilisation cycles using LTSF do not alter the structure of most (11/14) respirators tested and did not degrade the fit or filtration capacity of any of the analysed respirators. The residual formaldehyde levels comply with the EN 14180 standard. This reprocessing method could be used in times of shortage of personal protective equipment.

An outbreak of a new Coronavirus called SARS-CoV-2 (COVID- 19) was detected in December 2019 in the Wuhan Province of China. This highly contagious virus spread quickly to other countries and, a few weeks later, the World Health Organization (WHO) declared it a pandemic. [1] The virus is mainly transmitted among humans through secretions in the form of "respiratory droplets" larger than 5 microns that can travel a distance of up to 1-2 metres; and through contact with fomites or surfaces where these droplets have landed. Therefore, transmission control recommendations consist of droplet and contact precautions, including the use of surgical masks. Additionally, for procedures capable of generating aerosols, airborne precautions are recommended that include the use of Filtering Facepiece (FFP) type respirators. [2, 3] Surgical masks are single-use items; FFP respirators are generally discarded after use, but may be treated as limited-use devices, i.e. they can be reused for a limited time, unless there is a risk of contamination by deposits of infectious particles on the surface. For example, when caring for patients with tuberculosis, it is acceptable for the same health worker to reuse a respirator for a limited number of times. If the respirator gets wet, is splashed with body fluids, does not fit properly, and after performing aerosol generating procedures, it must be discarded. [4] SARS-CoV-2 survives in the environment, including on surfaces of various materials such as iron, cardboard, and textiles, so the outer surface of surgical masks and respirators can become contaminated quickly, causing a risk of infection when they are reused. [5, 6] FFP Respirators are classified from lower to higher filtration capacity, as FFP1, FFP2 and FFP3 according to UNE 149:2001; and as N95, N99 and N100 according to The National Institute for Occupational Safety and Health, (NIOSH), an affiliate agency of the Centers for Disease Control and Prevention (CDC) in the United States. [7, 8] The acute lack of personal protective equipment (PPE) available to healthcare centres, particularly respirators, has made decontamination essential, and since the 2009 H1N1 pandemic, quick and easy methods that use equipment already available in healthcare centres have been used. [9] [10] [11] [12] [13] [14] [15] J o u r n a l P r e -p r o o f

The study was carried out at the Hospital Universitario Ramón y Cajal, from 25th March to 23th

April 2020. The Ramón y Cajal Hospital is a public hospital with 1 118 beds, in the northern area of Madrid (Spain), a region with one of the highest number of patients hospitalised with COVID-19 in our country. It provides specialised assistance to 558 373 citizens who represent 8.51% of the population of Madrid.

The performance of 14 unused, N95, FFP2 and FFP3-type cellulose-free respirator models was evaluated. The study sample selection was opportunistic and consisted of the types of respirator available to hospital during the pandemic.

Three units of each respirator model were used: one unit per each phase of the research (baseline, after one sterilisation cycle, and after two sterilisation cycles). In these phases, the following variables were recorded: external appearance of the respirators, flexibility and integrity of the elastic bands and other components and fit factor (FF). At the end of the second cycle, the accumulated residual formaldehyde on the respirators was measured. Additionally, in five respirator models, the filtering capacity was assessed in each phase. A quantitative fit test was performed, which can be used to perform fit tests on any close-fitting respirator. An instrument was used to test for possible leaks around the facial seal which produces the numerical result called FF, which is the ratio between the concentration of microscopic particles detected outside the respirator and the concentration of particles detected inside. A continuous flow condensation particle counter (CPC), the TSI 8038 PortaCount® Pro+Respirator Fit Tester (TSI Incorporated, Shoreview -MN, USA), which uses an ambient aerosol and does not require the use of a test chamber was used. [20] All the tests were J o u r n a l P r e -p r o o f performed with the same human subject, a 42-year-old male, slim build, clean shaven, nonsmoker, with no pre-existing conditions and no signs or symptoms of COVID-19 or any other respiratory disease. The subject had not eaten any food or drink during the previous 30 minutes (as required for the test) and was at ease, standing, and breathing normally. All measurements were taken in the same room, a 33.85 m 3 room, with a controlled environment, at a stable temperature between 25 and 26ºC, with no draughts and 10.7 air renewals per hour. The subject was instructed on the correct placement of the respirators; he put the respirator on 5 minutes before starting the measurement, without outside help, and was not allowed to adjust the fit during the test. Once in place, measuring tubes were attached to a strap to prevent them from exerting any traction on the respirator that would alter the FF. Seven consecutive FF measurements were taken for one minute at regular 10-second intervals. Photographs were taken of each of the measurements of the respirators in position on the subject and their condition before and after the reprocessing cycles. The median value and quartiles of FF in baseline condition and after each reprocessing cycle was calculated through the software Stata 15 ® . Subsequently, the FF differences between baseline and after one and two sterilization cycles were analysed (unpaired samples Mann-Whitney u test) for detecting differences in the fitting capacity due to the sterilization process.

Additionally, for five of the respirator models selected opportunistically according to their (Table I) .

Regarding the quantification of residual formaldehyde in the processed respirators, all values were below 5 µg/cm 2 , the permissible threshold in materials according to EN 14180:2014 (Table I) .

Regarding the FF, six models (Bimedica Naturcare ® , Dromex ® 3231, Garry Galaxy, Pioneer® Safety EP005, PURVIGOR KN95, and VENUS V-420-V) obtained a FF < 100. Among the other eight models, the following changes with a p-value < 0.05 were obtained with respect to the baseline: after one reprocessing cycle, one model decreased with a resulting FF < 100 (Oxyline (Table II ).

All the models tested by the INSST gave satisfactory results in the visual inspection. In the NaCl aerosol penetration test, three models (3M TM Aura TM , Garry Galaxy and Venus V-420V) obtained results equivalent or superior to the FFP classification with which they had been marketed, both in their baseline state and after one and two decontamination cycles. The (Table III) .

It is considered that hospitals should have a sufficient supply to provide one respirator per worker per shift in critical, surgical and assisted ventilation units, and one for extended use, depending on the workload of health care workers who deal with patients on the ward or in the emergency room. [21] The requirement for respirators according to these calculations can only be satisfied in normal conditions. Since the 2009 H1N1 flu pandemic, concern about a potential shortage of respirators has led to numerous studies of reprocessing methods that allow safe reuse using equipment already available in hospitals. [9] [10] [11] [12] [13] [14] [15] FFP respirator manufacturers do not presently authorise decontamination or reuse in their technical data sheets, and although it is only they who can provide reliable guidance on how to decontaminate their products, several reports on different decontamination methods have been published in recent weeks. In March this year, the Dutch Institute for Public Health and the Environment (Rijksinstituut voor Volksgezondheid en Milieu -RIVM-) carried out a pilot study on the reprocessing of FFP2 respirators, which concluded that the respirators maintain their shape and capacity to retain particles after having been sterilised once and twice with hydrogen peroxide. [22] Weeks later, the United States Food and Drug Administration (FDA), issued an Emergency Use Authorization (EUA) to allow the use of a sterilisation chamber hydrogen peroxide system to decontaminate N95 respirators. [23] This authorisation is based on an extensive study carried out in 2016 on an N95 model (3M 1860) which shows that the structural and functional characteristics of the respirators were not damaged after 50 processing cycles.

The study showed the effectiveness of the system for a 6-log reduction of Geobacillus stearothermophilus spores. [15] The U.S. NIOSH National Personal Protective Technology Laboratory (NPPTL) has investigated the impact of several decontamination methods on filtration efficiency, the fit of FFP respirators to the face, and the ability to reduce viable viruses and bacteria in these respirators; and recommends further research in the area of ultraviolet germicidal irradiation (UVGI), vaporous hydrogen peroxide (VHP), and moist heat decontamination. [24] The COVID-19 pandemic has led to a considerable shortage of PPE, making it necessary to consider reuse. We decided to study respirator decontamination using the low-temperaturesteam-2%-formaldehyde sterilisation process rather than hydrogen peroxide or UV radiation sterilisation for several reasons. The antimicrobial activity (including vegetative bacteria, fungi, viruses and spores) of formaldehyde in steam form as a sterilising agent, and its penetrability have been widely studied, documented, and used for the sterilisation of health-care J o u r n a l P r e -p r o o f material. [25, 26] No special packaging or subsequent aeration is required, any sterilisation packaging that complies with UNE-EN ISO 11607-1 can be used and it is compatible with most materials, other than polycarbonate and latex. Although we also have hydrogen peroxide plasma gas sterilizers, we chose the LTSF based on the lowest cost per cycle, and because unlike hydrogen peroxide sterilisation, the system is regulated by a specific standard (EN 14180:2014) , thus giving more guarantees for user safety. [19] The cycle time of 153 minutes at 78ºC, despite being longer than that of the hydrogen peroxide sterilizer, still makes respirators available for reuse in a time frame that meets current requirements. In addition, the LTSF system enables a parametric release of materials (EN 14180:2014) , saving time in materials management in the Central Sterilisation Department, provided that the sterilizers are validated according to ISO 25424. [18] The accumulated formaldehyde residue testing on the respirators after two decontamination cycles was always below 5 µg/cm 2 , the threshold recommended by EN 14180:2014, being even "not detectable" (value equivalent to the obtained in the sample used as a comparison control) in some respirators.

However, formaldehyde is a recognized carcinogen that has been associated with nasopharyngeal carcinoma and other diseases. [27] The correct placement of a respirator will always imply its proximity to the upper respiratory tract, hence it will be close to susceptible tissues to the damaging action of this compound. Therefore, although different formaldehyde concentration thresholds established as safe by different guides or institutions could be respected, it will always be preferable to obtain a "not detectable" formaldehyde residue.

Aerosol penetration tests performed in five respirator models by INSST proved that four of them maintained their filtering capacity after two reprocessing cycles. However, PURVIGOR KN95 3D model performed like FFP1 instead of FFP2.

Only three of the 14 models showed visible physical changes after decontamination. The nasal fit of the respirators after decontamination appears to be better in models with an adjustable nasal rod integrated into the fabric than those with the rod over the respirator structure, and it is possible that the surface exposure of the metal rod increases the thermolability of the product.

The results of this study suggest that as well as mandatory technical requirements, healthcare institutions should consider other variables like respirator design and number of parts when purchasing these products.

As for FF, The Occupational Safety and Health Administration states that FF should never be below 100 to ensure a safe fit. [28] However, we obtained lower values from our measurements with several models, which could be explained by the methodology used. In our study, the user was provided with general training in the use of respirators, but this was not individualised for each model and the test was performed even when the initial FF was below 100. Moreover, the absolute FF values are only applicable, by definition, to the specific test subject, and not to the entire population. In addition, health professionals do not usually have the option of calculating the FF of each respirator in real time, so in the study replicated their real working conditions.

The results obtained with several deteriorations and improvements of the FF respirator models, both after one and two sterilisation cycles, confirm the preliminary character of this research and could be explained by study limitations as the small sample size in the FF assessment or the FF measurement with a single test subject. Also, the use of one different unit of each respirator model for each phase of the research could affect this and other results of the study, due to the possible variability existing between different units of the same respirator model.

Healthcare workers may become infected in clinical environments through exposure to a minimal number of microorganisms, so the correct fit of a respirator is a key factor for ensuring it provides effective protection. [29, 30] Spain is one of the countries with the highest number of coronavirus infections among healthcare workers, accounting for 20% of total number cases as of 21 April, according to data issued by the Spanish Ministry of Health to the European Centre for Disease Prevention and Control. [31] Therefore, consideration should be given to including individual FF measurements of the respirator models used in each hospital in respiratory protection programmes regulating worker safety, and if this is not feasible, at least for staff who are usually assigned to higher risk areas, such as Intensive Care Units, infectious disease services and emergency departments.

If this research would be applied to the real practice, it would be desirable to repeat the filtration test, FF, and formaldehyde residue analysis for each model intended to be reused, because of the variations that can be found between different respirator models. Likewise, due to the importance of the proper fitting to the user's face, if a particular respirator unit is sterilised for reuse, it should be uniquely identified, to later be returned to its original user.

Regarding study limitations, it should be noted that the sample analysed was selected opportunistically using the respirator models available to staff at the time, and there were few units of each model analysed. Due to shortages, the supply of respirators changed frequently, which made it impossible to carry out the evaluations on all models, and it was only possible to subject the penetration test in five of 14 respirators. In any case, the results of this study represent preliminary investigations and should be interpreted with caution. Therefore, it would be necessary to analyse a greater number of respirators and models to achieve more robust results.

Among the strengths of the study are that the reprocessing system was performed under similar conditions to real practice. All the residual formaldehyde and the different phases of the decontamination system were performed according to valid international standards. In addition, the research was carried out on a large sample of models of different brands of respirators, obtaining results consistent with the initial study hypothesis.

Despite the limitations mentioned above, the results of this study show that subjecting certain models of FFP2, FFP3 or N95 respirators to one or two decontamination cycles with 2% LTSF does not compromise their structure, ability to fit or filtering capacity. Furthermore, the formaldehyde residue results comply with the EN 14180 standard, and this technique may be used in cases of respirator shortages like the current situation.

Declarations of interest: none.

The authors received no specific funding for this work. Three units of each respirator model were used, one of them for each phase of the research (baseline, after one sterilization cycle, and after two sterilization cycles).

World Health Organization. Coronavirus disease (COVID-2019) situation reports

World Health Organization. Rational use of personal protective equipment (PPE) for coronavirus disease (COVID-19): interim guidance

The SARS epidemic in Hong Kong: what lessons have we learned?

Cloth masks and mask sterilisation as options in case of shortage of surgical masks and respirators

Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents

AVIS SF2H du 14 mars 2020 relatif aux conditions de prolongation du port ou de réutilisation des masques chirurgicaux et des appareils de protection respiratoire de type FFP2 pour les professionnels de santé

Respiratory protective devices -Filtering half masks to protect against particles -Requirements, testing

National Institute for Occupational Safety and Health (NIOSH)

A pandemic influenza preparedness study: Use of energetic methods to decontaminate filtering facepiece respirators contaminated with H1N1 aerosols and droplets

Effectiveness of three decontamination treatments against influenza virus applied to filtering facepiece respirators

Evaluation of five decontamination methods for filtering facepiece respirators

Evaluation of Multiple (3-Cycle) Decontamination Processing for Filtering Facepiece Respirators

Impact of three biological decontamination methods on filtering facepiece respirator fit, odor, comfort, and donning ease

Impact of Three Cycles of Decontamination Treatments on Filtering Facepiece Respirator Fit

Final Report for the Bioquell Hydrogen Peroxide Vapor (HPV) Decontamination for Reuse of N95 Respirators

Gobierno de España. Límites de exposición profesional para agentes químicos en España

International Organization for Standardization

Sterilization of health care products -Low temperature steam and formaldehyde -Requirements for development, validation and routine control of a sterilization process for medical devices

European Committee for Standardization. European Standard EN 14180 Sterilizers for medical purposes -Low temperature steam and formaldehyde sterilizers -Requirements and testing

Occupational Safety and Health Administration (OSHA). Respirator Fit Testing

Real Decreto 664/1997, de 12 de mayo, sobre la protección de los trabajadores contra los riesgos relacionados con la exposición a agentes biológicos durante el trabajo

The Dutch National Institute for Public Health and the Environment (RIVM National Institute for Public Health and the Environment. Reuse of FFP2 masks n

Emergency Use Authorization to decontaminate compatible N95 or N95-equivalent respirators for reuse by health care workers in hospital settings

Decontamination and Reuse of Filtering Facepiece Respirators

A comparative study of ethylene oxide gas, hydrogen peroxide gas plasma, and low-temperature steam formaldehyde sterilization

Microbiological efficacy of Sterrad 100S and LTSF sterilization systems compared to ethylene oxide

Formaldehyde Carcinogenicity Research: 30 Years and Counting for Mode of Action, Epidemiology, and Cancer Risk Assessment

Fit Testing Procedures (Mandatory). -1910.134 App A n

National Institute for Occupational Safety and Health (NIOSH). 42 CFR Part 84

Respiratory Protective Devices

Sensitivity and specificity of the user-sealcheck in determining the fit of N95 respirators

Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK -ninth update